TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549​ SCHEDULE 14 A Proxy Statement Pursuant to Section 14 of the Securities Exchange Act of 1934 Filed by the ...

This came after Bayer Pharmaceutical presented the proposal for a grant of permission to import and market the drug ...